Latest / The BioHub - by Avetix
Episode 229 - Frederic Marrache - CEO of Bionyra
On this episode we feature the CEO of Bionyra, Frederic Marrache, after closing French-biotech's largest ever Series A ($165million) this summer.
Bionyra are a Sofinnova-incubated I&I biotech advancing in-licensed monoclonal (TL1A & IL25) & bispecific (TL1AxIL-23p19) HLE antibodies for a range of autoimmune indications. In this conversation we discuss why, after a decade within Sanofi's I&I development organisation, Frederic viewed the Bionyra opportunity as 'the one' to scratch his biotech itch.
Naturally, we then discuss the promise of their technology which led to the likes of Jeito &…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.